Universal Health Services Inc
UHSNYSECIK 352915HealthcareFiscal year ends Dec 31
Reports and events: 282 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2717:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-434414 |
| 2026-08-2107:58 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-359953 |
| 2026-08-1716:15 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-354078 |
| 2026-08-1309:23 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-348057 |
| 2026-08-0716:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-340278 |
| 2026-07-2808:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-318940 |
| 2026-07-2116:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-310330 |
| 2026-05-2207:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-235480 |
| 2026-05-2107:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-233402 |
| 2026-05-0716:17 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-211992 |
| 2026-04-2808:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-183643 |
| 2026-04-2408:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-175197 |
| 2026-04-0906:30 ET | DEF 14A | Proxy statementPeriod 2026-05-20 | 0001193125-26-148814 |
| 2026-03-3017:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-131809 |
| 2026-03-0908:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-097674 |
| 2026-02-2608:15 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-073545 |
| 2026-02-2516:21 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-071676 |
| 2025-12-3108:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-337662 |
| 2025-11-0716:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-272385 |
| 2025-10-2808:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-252399 |
| 2025-09-2908:30 ET | 8-K | 8.01 Other events | 0001193125-25-221802 |
| 2025-08-0816:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105857 |
| 2025-07-2908:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-099405 |
| 2025-05-1516:15 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-072647 |
| 2025-05-0816:16 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-067010 |
| 2025-04-2908:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-059583 |
| 2025-04-0306:30 ET | DEF 14A | Proxy statementPeriod 2025-05-14 | 0000950170-25-049925 |
| 2025-03-2016:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-042671 |
| 2025-02-2708:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-028406 |
| 2025-02-2616:20 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-027785 |
| 2024-11-0816:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-124103 |
| 2024-10-2508:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-117220 |
| 2024-10-1116:15 ET | 8-K | 8.01 Other events | 0000950170-24-114325 |
| 2024-10-0108:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-229561 |
| 2024-09-3007:00 ET | 8-K | 8.01 Other events | 0000950170-24-110165 |
| 2024-09-1916:21 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-222126 |
| 2024-08-0816:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094006 |
| 2024-07-2508:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-086313 |
| 2024-05-1607:00 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-060793 |
| 2024-05-0816:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055683 |
| 2024-04-2508:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-047947 |
| 2024-04-0406:30 ET | DEF 14A | Proxy statementPeriod 2024-05-15 | 0001193125-24-086555 |
| 2024-04-0108:15 ET | 8-K | 8.01 Other events | 0000950170-24-038889 |
| 2024-03-2516:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-035902 |
| 2024-02-2808:52 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021681 |
| 2024-02-2716:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021193 |
| 2024-02-2716:18 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-021175 |
| 2024-01-0209:03 ET | 8-K | 8.01 Other events | 0000950170-24-000014 |
| 2023-11-0816:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061147 |
| 2023-10-2608:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-055374 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:04 ET. Listed shows no prices and gives no investment advice.